Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery

被引:82
|
作者
Kheterpal, Sachin [1 ]
Khodaparast, Omeed [2 ]
Shanks, Amy [1 ]
O'Reilly, Michael [1 ]
Tremper, Kevin K. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI 48103 USA
[2] Baylor Univ, Med Ctr, Dept Anesthesiol, Dallas, TX 75246 USA
关键词
angiotensin-converting enzyme inhibitor; intraoperative hypotension; diuretics;
D O I
10.1053/j.jvca.2007.12.020
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: Chronic angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) therapy has been reported to result in intraoperative hypotension in patients undergoing general anesthesia. This study evaluated the association between ACE-I/ARB therapy and the hemodynamics of patients undergoing noncardiac surgery using a large patient dataset. Design and Setting: A prospective, observational study performed at a single tertiary care hospital. Participants: All adult patients undergoing noncardiac surgery. Interventions: None. Measurements and Main Results: Propensity score matching for the likelihood of chronic ACE-I/ARB therapy was used to create 2 patient cohorts with similar cardiovascular and pulmonary comorbidities. The number of periods of absolute and relative hypotension, vasopressor requirements, and postoperative myocardial infarction and renal failure rates were compared among patients with and without ACE-I/ARB therapy. A total of 65,043 noncardiac cases be-tween 2003 and 2006 were included. Two-digit propensity score matching resulted in a study population of 12,381 operative cases with very similar cardiovascular comorbidities between the ACE-I/ARB and control cohort. Patients with chronic ACE-I/ARB and diuretic therapy showed more periods with a mean arterial pressure <70 mmHg, periods with a 40% decrease in systolic blood pressure, periods with a 50% decrease in systolic blood pressure, and vasopressor boluses when compared with patients with diuretic therapy alone. There were no statistically significant differences in the rates of postoperative myocardial infarction or renal failure between patients with and without ACE-I/ARB therapy. Conclusions: Chronic diuretic therapy is associated with more frequent hypotension in ACE-I/ARB-treated patients undergoing noncardiac surgery. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:180 / 186
页数:7
相关论文
共 50 条
  • [21] Angiotensin-converting enzyme inhibitor versus angiotensin 2 receptor antagonist therapy and the influence of angiotensin-converting enzyme gene polymorphism in IgA nephritis
    Woo, Keng-Thye
    Lau, Yeow-Kok
    Chan, Choong-Meng
    Wong, Kok-Seng
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2008, 37 (05) : 372 - 376
  • [22] Optimal dose of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker for renoprotection
    Hou, Fan Fan
    Zhou, Qiu Gen
    NEPHROLOGY, 2010, 15 : 57 - 60
  • [23] Comparative efficacy of combined therapy with angiotensin converting enzyme inhibitor and angiotensin receptor blocker and direct renin inhibitor in patients with severe chronic heart failure
    Tumasyan, L. R.
    Adamyan, K. G.
    EUROPEAN HEART JOURNAL, 2010, 31 : 463 - 464
  • [24] Effect of combination angiotensin-converting enzyme and angiotensin receptor blocker therapy on heart failure mortality and morbidity
    Kapoor, John R.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (05): : 744 - 745
  • [25] A CLINICAL EVALUATION OF HYPERKALAEMIA IN PATIENTS WITH RENAL IMPAIRMENT ON COMBINATION THERAPY OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN-RECEPTOR BLOCKER
    Goh, T. H.
    Tan, S. C.
    Fook-Chong, S. M. C.
    Wong, K. S.
    Chan, C. M.
    NEPHROLOGY, 2005, 10 : A139 - A139
  • [26] Efficacy of combination therapy with angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertension
    Redon, Josep
    Trenkwalder, Peter R. A.
    Barrios, Vivencio
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (02) : 155 - 164
  • [27] Combined angiotensin converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB) therapy is safe and effective in kidney transplant patients
    Reilly, James B.
    Goral, Simin
    Bloom, Roy D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 533 - 533
  • [28] Angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use and outcomes in patients with colorectal cancer
    Tuazon, Sherilyn Alvaran
    King, Gantry Teng
    Cruz, Joanna Sta.
    Chae, Young K.
    Koc, Jean B. Ong Klan
    Hegarty, Sarah
    Leighton, John Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With Proteinuria
    Chu, Chi D.
    Powe, Neil R.
    Estrella, Michelle M.
    Shlipak, Michael G.
    McCoy, Ian E.
    Tuot, Delphine S.
    MAYO CLINIC PROCEEDINGS, 2022, 97 (11) : 2099 - 2106
  • [30] Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide
    Sata, N
    Tanaka, Y
    Suzuki, S
    Kamimura, R
    Mifune, H
    Nakamura, K
    Miyahara, K
    Arima, T
    CIRCULATION JOURNAL, 2003, 67 (12) : 1053 - 1058